Annual Jefferson ILD Symposium
Philadelphia, United States (USA), October 10, 2025
TL;DR
The 3rd Annual Jefferson Interstitial Lung Disease Conference is designed to provide healthcare professionals with a comprehensive overview of the latest advances in the diagnosis, management, and treatment of ILD. This educational activity will feature expert-led lectures, interactive case discussions, and evidence-based updates on current and emerging therapies...
About the Event
Participants will gain insights into the evolving understanding of ILD pathophysiology, including idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD, hypersensitivity pneumonitis, and other fibrosing lung diseases.
Special emphasis will be placed on diagnostic challenges, multidisciplinary care models, and the role of high-resolution imaging, serologies, and lung biopsy in clinical decision-making. Attendees will also explore updates on pharmacologic therapies, including antifibrotic agents and immunomodulators.
This conference aims to foster knowledge exchange, promote best practices, and support the delivery of high-quality, patient-centered ILD care across various practice settings.
Organization
Annual Jefferson ILD Symposium is organized by Thomas Jefferson University
Date and Location
The symposium will take place in Philadelphia, United States (USA) on October 10, 2025.
Attendance to the this symposium is Online.
For more information, you can click here to access to the event website.